June 7, 2021 Price forecast | 2 weeks: -0.77% | 1 month: -1.18% | 3 months: -1.69%


SYNH stock forecast

Our latest prediction for Syneos Health Inc's stock price was made on the June 7, 2021 when the stock price was at 80.71$.

In the short term (2weeks), SYNH's stock price should underperform the market by -0.77%. During that period the price should oscillate between -5.59% and +4.34%.

In the medium term (3months), SYNH's stock price should underperform the market by -1.69%. During that period the price should oscillate between -16.07% and +11.13%.

Create a solid portfolio with SYNH

Add SYNH to your portfolio and optimize it!


About Syneos Health Inc

Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit syneoshealth.com.

At the moment the company generates 4461M USD in revenues.

On its last earning announcement, the company reported a profit of 1.88$ per share.

The book value per share is 27.43$

Syneos Health Inc website


Three months stock forecastJune 7, 2021


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
4461M 23.40% 363M 8.10% 198M 1.88 - - 105M 27.43 591M -49M 542M